Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000118278 | SCV000171582 | benign | not specified | 2013-12-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000118278 | SCV000225659 | benign | not specified | 2014-11-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000231542 | SCV000289934 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313919 | SCV000847376 | benign | Inborn genetic diseases | 2016-06-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002490811 | SCV002796067 | benign | Cognitive impairment with or without cerebellar ataxia; Developmental and epileptic encephalopathy, 13; Seizures, benign familial infantile, 5; Myoclonus, familial, 2 | 2021-10-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004706538 | SCV005228870 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000118278 | SCV000152650 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |